Literature DB >> 15364271

High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.

Jean-Luc Prétet1, Véronique Dalstein, Sylvain Monnier-Benoit, Sébastien Delpeut, Christiane Mougin.   

Abstract

BACKGROUND: High risk human papillomavirus (HR-HPV) load determined by quantitative methods has already been considered as highly predictive of future development of high grade cervical lesions. Some studies also demonstrated that Hybrid Capture II (HCII) results can be considered as a reflection of HPV DNA load, while others did not. HCI assay, well suited for routine HR-HPV screening, is not especially dedicated for quantitative use. However, we have recently shown that women with high viral loads assessed by HCII were at increased risk of cervical precancer.
OBJECTIVES: The aim of the study was to determine if the values given by the HCII assay can be considered as quantitative. STUDY
DESIGN: We used a real-time PCR allowing precise quantification of both HPV16 genome and albumin gene to normalize the measuring HPV16 load in cervical cells and to compare the data with those obtained by HCIIin a series of 40 HR-HPV positive samples.
RESULTS: Reproducibility of the HPV16 real-time PCR, assessed from nine independent experiments of serial dilutions of SiHa cell DNA, was reflected in coefficients of variation for standard curves of crossing point (Cp) values below 5%. The HPV16 loads with a broad individual variability were significantly related to the cumulative load estimated by HCII and did not depend on the cellularity of samples.
CONCLUSIONS: We assume that the HCII values can be used as a quantitative measure of HR-HPV DNA, so long as cervical specimens are collected using standardized protocols.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364271     DOI: 10.1016/j.jcv.2004.02.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  10 in total

1.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.

Authors:  Christopher Payan; Alexandra Ducancelle; Mohamed H Aboubaker; Julien Caer; Malena Tapia; Amelie Chauvin; Damien Peyronnet; Elodie Le Hen; Zohra Arab; Marie-Christine Legrand; Adissa Tran; Edith Postec; Françoise Tourmen; Martine Avenel; Chantal Malbois; Marie-Anne De Brux; Philippe Descamps; Francoise Lunel
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens.

Authors:  A T Hesselink; A J C van den Brule; Z M A Groothuismink; M Molano; J Berkhof; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens.

Authors:  Nicolas Wentzensen; Patti E Gravitt; Rodney Long; Mark Schiffman; S Terence Dunn; J Daniel Carreon; Richard A Allen; Munira Gunja; Rosemary E Zuna; Mark E Sherman; Michael A Gold; Joan L Walker; Sophia S Wang
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

5.  Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Authors:  Jennifer R Moodley; Deborah Constant; Margaret Hoffman; Anna Salimo; Bruce Allan; Ed Rybicki; Inga Hitzeroth; Anna-Lise Williamson
Journal:  BMC Cancer       Date:  2009-08-07       Impact factor: 4.430

6.  A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.

Authors:  Nicolas Wentzensen; Patti E Gravitt; Diane Solomon; Cosette M Wheeler; Philip E Castle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

7.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

8.  Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix.

Authors:  C-M Ho; W-F Cheng; T-Y Chu; C-A Chen; M-H Chuang; S-F Chang; C-Y Hsieh
Journal:  Br J Cancer       Date:  2006-10-24       Impact factor: 7.640

9.  The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial.

Authors:  Yu-Che Ou; Hung-Chun Fu; Chih-Wen Tseng; Chen-Hsuan Wu; Ching-Chou Tsai; Hao Lin
Journal:  BMC Womens Health       Date:  2019-07-24       Impact factor: 2.809

10.  Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples.

Authors:  David Guenat; Véronique Dalstein; Frédéric Mauny; Maëlle Saunier; Jenny Briolat; Christine Clavel; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  Papillomavirus Res       Date:  2018-10-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.